Research ArticleHuman Studies
Measurement of PDT-Induced Hypoxia in Dunning Prostate Tumors by Iodine-123-Iodoazomycin Arabinoside
Ronald B. Moore, J. Donald Chapman, John R. Mercer, Rezaul H. Mannan, Leonard I. Wiebe, Alexander J. McEwan and Malcolm S. McPhee
Journal of Nuclear Medicine March 1993, 34 (3) 405-411;
Ronald B. Moore
J. Donald Chapman
John R. Mercer
Rezaul H. Mannan
Leonard I. Wiebe
Alexander J. McEwan


This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Measurement of PDT-Induced Hypoxia in Dunning Prostate Tumors by Iodine-123-Iodoazomycin Arabinoside
Ronald B. Moore, J. Donald Chapman, John R. Mercer, Rezaul H. Mannan, Leonard I. Wiebe, Alexander J. McEwan, Malcolm S. McPhee
Journal of Nuclear Medicine Mar 1993, 34 (3) 405-411;
Jump to section
Related Articles
- No related articles found.
Cited By...
- Understanding the hypoxic niche of multiple myeloma: therapeutic implications and contributions of mouse models
- Fractionated versus Standard Continuous Light Delivery in Interstitial Photodynamic Therapy of Dunning Prostate Carcinomas
- Effect of Tumor Host Microenvironment on Photodynamic Therapy in a Rat Prostate Tumor Model
- Treatment-Induced Changes in Tumor Oxygenation Predict Photodynamic Therapy Outcome
- Molecular Targeting with Radionuclides: State of the Science
- Marking Hypoxia in Rat Prostate Carcinomas with {beta}-D-[125I]Azomycin Galactopyranoside and [99mTc]HL-91: Correlation with Microelectrode Measurements
- Depletion of Tumor Oxygenation during Photodynamic Therapy: Detection by the Hypoxia Marker EF3 [2-(2-Nitroimidazol-1[H]-yl)-N-(3,3,3-trifluoropropyl)acetamide]